Ethyl 2-(5-bromo-1H-indol-1-yl)propionate, 95.0%, 250mg

(2R)-2-{benzyl[(tert-butoxy)carbonyl]amino}propanoic acid, 99.0%, 1g

4-(6-Hydroxyhexyloxy)-4'-methoxybiphenyl>95.0%(GC)1g

1,6-DIOXASPIRO[2.5]OCTANE-2-CARBONITRILE, 95.0%, 1g

methyl 1-(2-methoxyethyl)-1H-pyrazole-5-carboxylate, 95.0%, 5g

Phase contrast Abbe condenser with slide for E-Plan EPLPH 20/S100 phase contrast objectives, slide with 20 and 100x phases, telescope and green filter

3-Fluoro-5-nitrobenzonitrile, 95.0%, 5g

{2-[(4-methyl-1-piperidinyl)methyl]phenyl}methanol hydrochloride, 95.0%, 5g

3-Fluoro-5-iodopyridin-4-amine, 97%, 10g

5-Bromo-4-chloro-3-indolyl-�-D-glucuronic acid - cyclohexylammonium salt, >97%, 250mg

(S)-(-)-1-Methyl-2-pyrrolidinemethanol, 97.0%, 25g

2,8-Dibromodibenzo[b,d]furan, 95.0%, 500g

4-hydroxy-3-[(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl]-2H-chromen-2-one, 98.0%, 25g